People · Operator
Named in public records as an officer, director or promoter · active 2020–2024 · Other, Other Technology, Healthtech
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Cribl, Inc. | — | Other | Series D+ | $388.8M | $1.3B | 2020 |
| StarTree, Inc. | — | Other Technology | Series C | $71.0M | $793.5M | 2022 |
| Superconductive Health, Inc. | — | Healthtech | Series B | $61.0M | $716.3M | 2021 |
Max Gazor at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Max Gazor on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Glenn Solomon | 1 | 15 |
| Enrique Salem | 1 | 12 |
| Pat Grady | 1 | 5 |
| James Campbell | 1 | 5 |
| Zachary Johnson | 1 | 2 |
| Bryan Offutt | 1 | 2 |
| Kishore Gopalakrishna | 1 | 1 |
| Abe Gong | 1 | 1 |
| Elizabeth Immen | 1 | 1 |
| Ben Castleton | 1 | 1 |
| Michael McBride | 1 | 1 |
| Ledion Bitincka | 1 | 1 |
| Matthew Kelly | 1 | 1 |
| Clint Sharp | 1 | 1 |
| Dritan Bitincka | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.